Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.

Antiviral therapy - 1 Jan 2006

Marcelin Anne-Genevieve, Flandre Philippe, Furco Andre, Wirden Marc, Molina Jean-Michel, Calvez Vincent

Abstract excerpt

OBJECTIVE: To determine the potential impact of reverse transcriptase (RT) mutations, other than those currently known to confer nucleoside reverse transcriptase inhibitors (NRTIs) resistance, on the virological response to didanosine (ddl). DESIGN AND PATIENTS: In the placebo-controlled Jaguar trial, 168 patients were randomly assigned to receive ddl (n=111) or placebo (n=57) in addition to their currently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Codon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Didanosine

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 17310813

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.PMID 17310813Read ↗

An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.Semantic proximity Read ↗

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.Semantic proximity Read ↗

Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.Semantic proximity Read ↗

Clinically relevant genotype interpretation of resistance to didanosine.Semantic proximity Read ↗

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapySemantic proximity Read ↗

The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.Semantic proximity Read ↗

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.Semantic proximity Read ↗

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adultsSemantic proximity Read ↗

Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

Genetic basis of variation in tenofovir drug susceptibility in HIV-1.Semantic proximity Read ↗

Reverse transcriptase genotype and antiretroviral susceptibility of human immunodeficiency virus isolates from patients with advanced disease treated with didanosine: correlation with virologic response and survival.Semantic proximity Read ↗

Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.